EP Patent
EP2496220B1 — Modified release formulation of lacosamide
Assigned to Lupin Ltd · Expires 2019-10-16 · 7y expired
What this patent protects
Patent listed against Vimpat.
Drugs covered by this patent
- Vimpat (lacosamide) · UCB
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.